Loading…
The study of the serum level of IL‐4, TGF‐β, IFN‐γ, and IL‐6 in overweight patients with and without diabetes mellitus and hypertension
Background Obesity increases the risk of diabetes mellitus (DM) and hypertension. We aimed to analyze the serum levels of cytokines that have relevance to the pathologies including, interleukin‐4 (IL‐4), transforming growth factor‐β (TGF‐β), interferon‐γ (IFN‐γ), and IL‐6 cytokines of overweight men...
Saved in:
Published in: | Journal of cellular biochemistry 2019-03, Vol.120 (3), p.4147-4157 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c3530-eedf07bc029ee60529a943876a670ac986ce59daeec2cf958f9120c754fc560c3 |
---|---|
cites | cdi_FETCH-LOGICAL-c3530-eedf07bc029ee60529a943876a670ac986ce59daeec2cf958f9120c754fc560c3 |
container_end_page | 4157 |
container_issue | 3 |
container_start_page | 4147 |
container_title | Journal of cellular biochemistry |
container_volume | 120 |
creator | Asadikaram, Gholamreza Ram, Maryam Izadi, Alireza Sheikh Fathollahi, Mahmood Nematollahi, Mohammad Hadi Najafipour, Hamid Shahoozehi, Bidollah Mirhoseini, Mahboobeh Masoumi, Mohammad Shahrokhi, Nader Arababadi, Mohammad Kazemi |
description | Background
Obesity increases the risk of diabetes mellitus (DM) and hypertension. We aimed to analyze the serum levels of cytokines that have relevance to the pathologies including, interleukin‐4 (IL‐4), transforming growth factor‐β (TGF‐β), interferon‐γ (IFN‐γ), and IL‐6 cytokines of overweight men with DM and/or hypertension.
Methods
The study collected serum from 164 men. The sample population contained, 54 overweight men without DM or hypertension (control [CTL] group), 36 men with both DM and hypertension (DH group), 20 men with DM but no hypertension (D group), and 54 had hypertension without DM (H).
Results
The main results showed that the concentration of IFN‐γ in the DH group was significantly higher than the D, H, and CTL groups, IL‐6 in DH and D groups was significantly lower than the CTL group. The serum level of TGF‐β and IL‐4 cytokines did not show any significant differences across the four groups. Serum levels of IL‐6 were also significantly lower in untreated patients in D group than controls and in DH when compared with H groups.
Conclusion
In conclusion, it appears that the proinflammatory and anti‐inflammatory cytokines either play a significant role in the pathogenesis of hypertension and DM or serve as markers for these pathologies. Accordingly, increased serum levels of IFN‐γ may participate in the pathogenesis of hypertension in the diabetic patients and decreased IL‐6 is associated with type 2 DM.
•Obesity increases the risk of diabetes (D) and hypertension in cytokines dependent manners.
•Interferon‐γ in diabetes/hypertension (DH) patients is significantly higher than D, H, and controls (CTL). DH and D have lower interleukin‐6 than CTL. It is also lower in untreated cases in D group than CTL and in DH than H. Transforming growth factor β is higher in the treated than untreated patients in DH group.
•It seems that cytokines play a significant role in the pathogenesis of hypertension in diabetes. |
doi_str_mv | 10.1002/jcb.27700 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2113275129</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2113275129</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3530-eedf07bc029ee60529a943876a670ac986ce59daeec2cf958f9120c754fc560c3</originalsourceid><addsrcrecordid>eNp1kc9uEzEQxi1UREPhwAtUlnoBKWnH9u46PkJESlBULuG8cryzxNH-SW1vo9x4BHgVeA8egifBmy09VOppvvH89M1YHyFvGFwyAH61NetLLiXAMzJioOQkyZLkhIxACphwwfgpeen9FgCUEvwFORXAMwAxHZGfqw1SH7riQNuShr5B19W0wjus-qfF8u_3H8mYrq7nUfz5NaaL-U2vfo-pbophnlHb0PYO3R7tt02gOx0sNsHTvQ2bI9aLtgu0sHqNAT2tsaps6Pxxujns0AVsvG2bV-R5qSuPr-_rGfk6_7iafZosv1wvZu-XEyPS-C3EogS5NsAVYgYpV1olYioznUnQRk0zg6kqNKLhplTptFSMg5FpUpo0AyPOyNvBd-fa2w59yGvrTbxKN9h2PueMCS5TxlVELx6h27ZzTbwuUnFd9GNppN4NlHGt9w7LfOdsrd0hZ5D3OeUxp_yYU2TP7x27dY3FA_k_mAhcDcDeVnh42in_PPswWP4D3S6gWA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2167056015</pqid></control><display><type>article</type><title>The study of the serum level of IL‐4, TGF‐β, IFN‐γ, and IL‐6 in overweight patients with and without diabetes mellitus and hypertension</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Asadikaram, Gholamreza ; Ram, Maryam ; Izadi, Alireza ; Sheikh Fathollahi, Mahmood ; Nematollahi, Mohammad Hadi ; Najafipour, Hamid ; Shahoozehi, Bidollah ; Mirhoseini, Mahboobeh ; Masoumi, Mohammad ; Shahrokhi, Nader ; Arababadi, Mohammad Kazemi</creator><creatorcontrib>Asadikaram, Gholamreza ; Ram, Maryam ; Izadi, Alireza ; Sheikh Fathollahi, Mahmood ; Nematollahi, Mohammad Hadi ; Najafipour, Hamid ; Shahoozehi, Bidollah ; Mirhoseini, Mahboobeh ; Masoumi, Mohammad ; Shahrokhi, Nader ; Arababadi, Mohammad Kazemi</creatorcontrib><description>Background
Obesity increases the risk of diabetes mellitus (DM) and hypertension. We aimed to analyze the serum levels of cytokines that have relevance to the pathologies including, interleukin‐4 (IL‐4), transforming growth factor‐β (TGF‐β), interferon‐γ (IFN‐γ), and IL‐6 cytokines of overweight men with DM and/or hypertension.
Methods
The study collected serum from 164 men. The sample population contained, 54 overweight men without DM or hypertension (control [CTL] group), 36 men with both DM and hypertension (DH group), 20 men with DM but no hypertension (D group), and 54 had hypertension without DM (H).
Results
The main results showed that the concentration of IFN‐γ in the DH group was significantly higher than the D, H, and CTL groups, IL‐6 in DH and D groups was significantly lower than the CTL group. The serum level of TGF‐β and IL‐4 cytokines did not show any significant differences across the four groups. Serum levels of IL‐6 were also significantly lower in untreated patients in D group than controls and in DH when compared with H groups.
Conclusion
In conclusion, it appears that the proinflammatory and anti‐inflammatory cytokines either play a significant role in the pathogenesis of hypertension and DM or serve as markers for these pathologies. Accordingly, increased serum levels of IFN‐γ may participate in the pathogenesis of hypertension in the diabetic patients and decreased IL‐6 is associated with type 2 DM.
•Obesity increases the risk of diabetes (D) and hypertension in cytokines dependent manners.
•Interferon‐γ in diabetes/hypertension (DH) patients is significantly higher than D, H, and controls (CTL). DH and D have lower interleukin‐6 than CTL. It is also lower in untreated cases in D group than CTL and in DH than H. Transforming growth factor β is higher in the treated than untreated patients in DH group.
•It seems that cytokines play a significant role in the pathogenesis of hypertension in diabetes.</description><identifier>ISSN: 0730-2312</identifier><identifier>EISSN: 1097-4644</identifier><identifier>DOI: 10.1002/jcb.27700</identifier><identifier>PMID: 30260038</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Antihypertensive Agents - therapeutic use ; Body weight ; cytokine ; Cytokines ; Cytotoxicity ; Diabetes ; Diabetes mellitus ; Diabetes Mellitus, Type 2 - blood ; Diabetes Mellitus, Type 2 - complications ; Diabetes Mellitus, Type 2 - drug therapy ; Diabetes Mellitus, Type 2 - pathology ; Growth factors ; Health risks ; Humans ; Hypertension ; Hypertension - blood ; Hypertension - complications ; Hypertension - drug therapy ; Hypertension - pathology ; Hypoglycemic Agents - therapeutic use ; immune system ; Inflammation ; Interferon ; Interferon-gamma - blood ; Interleukin-4 - blood ; Interleukin-6 - blood ; Interleukins ; Lymphocytes T ; Male ; Men ; Middle Aged ; obesity ; Obesity - blood ; Obesity - complications ; Overweight ; Pathogenesis ; Patients ; Serum levels ; Transforming growth factor ; Transforming Growth Factor beta - blood ; Transforming growth factor-b</subject><ispartof>Journal of cellular biochemistry, 2019-03, Vol.120 (3), p.4147-4157</ispartof><rights>2018 Wiley Periodicals, Inc.</rights><rights>2019 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3530-eedf07bc029ee60529a943876a670ac986ce59daeec2cf958f9120c754fc560c3</citedby><cites>FETCH-LOGICAL-c3530-eedf07bc029ee60529a943876a670ac986ce59daeec2cf958f9120c754fc560c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30260038$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Asadikaram, Gholamreza</creatorcontrib><creatorcontrib>Ram, Maryam</creatorcontrib><creatorcontrib>Izadi, Alireza</creatorcontrib><creatorcontrib>Sheikh Fathollahi, Mahmood</creatorcontrib><creatorcontrib>Nematollahi, Mohammad Hadi</creatorcontrib><creatorcontrib>Najafipour, Hamid</creatorcontrib><creatorcontrib>Shahoozehi, Bidollah</creatorcontrib><creatorcontrib>Mirhoseini, Mahboobeh</creatorcontrib><creatorcontrib>Masoumi, Mohammad</creatorcontrib><creatorcontrib>Shahrokhi, Nader</creatorcontrib><creatorcontrib>Arababadi, Mohammad Kazemi</creatorcontrib><title>The study of the serum level of IL‐4, TGF‐β, IFN‐γ, and IL‐6 in overweight patients with and without diabetes mellitus and hypertension</title><title>Journal of cellular biochemistry</title><addtitle>J Cell Biochem</addtitle><description>Background
Obesity increases the risk of diabetes mellitus (DM) and hypertension. We aimed to analyze the serum levels of cytokines that have relevance to the pathologies including, interleukin‐4 (IL‐4), transforming growth factor‐β (TGF‐β), interferon‐γ (IFN‐γ), and IL‐6 cytokines of overweight men with DM and/or hypertension.
Methods
The study collected serum from 164 men. The sample population contained, 54 overweight men without DM or hypertension (control [CTL] group), 36 men with both DM and hypertension (DH group), 20 men with DM but no hypertension (D group), and 54 had hypertension without DM (H).
Results
The main results showed that the concentration of IFN‐γ in the DH group was significantly higher than the D, H, and CTL groups, IL‐6 in DH and D groups was significantly lower than the CTL group. The serum level of TGF‐β and IL‐4 cytokines did not show any significant differences across the four groups. Serum levels of IL‐6 were also significantly lower in untreated patients in D group than controls and in DH when compared with H groups.
Conclusion
In conclusion, it appears that the proinflammatory and anti‐inflammatory cytokines either play a significant role in the pathogenesis of hypertension and DM or serve as markers for these pathologies. Accordingly, increased serum levels of IFN‐γ may participate in the pathogenesis of hypertension in the diabetic patients and decreased IL‐6 is associated with type 2 DM.
•Obesity increases the risk of diabetes (D) and hypertension in cytokines dependent manners.
•Interferon‐γ in diabetes/hypertension (DH) patients is significantly higher than D, H, and controls (CTL). DH and D have lower interleukin‐6 than CTL. It is also lower in untreated cases in D group than CTL and in DH than H. Transforming growth factor β is higher in the treated than untreated patients in DH group.
•It seems that cytokines play a significant role in the pathogenesis of hypertension in diabetes.</description><subject>Antihypertensive Agents - therapeutic use</subject><subject>Body weight</subject><subject>cytokine</subject><subject>Cytokines</subject><subject>Cytotoxicity</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Diabetes Mellitus, Type 2 - blood</subject><subject>Diabetes Mellitus, Type 2 - complications</subject><subject>Diabetes Mellitus, Type 2 - drug therapy</subject><subject>Diabetes Mellitus, Type 2 - pathology</subject><subject>Growth factors</subject><subject>Health risks</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Hypertension - blood</subject><subject>Hypertension - complications</subject><subject>Hypertension - drug therapy</subject><subject>Hypertension - pathology</subject><subject>Hypoglycemic Agents - therapeutic use</subject><subject>immune system</subject><subject>Inflammation</subject><subject>Interferon</subject><subject>Interferon-gamma - blood</subject><subject>Interleukin-4 - blood</subject><subject>Interleukin-6 - blood</subject><subject>Interleukins</subject><subject>Lymphocytes T</subject><subject>Male</subject><subject>Men</subject><subject>Middle Aged</subject><subject>obesity</subject><subject>Obesity - blood</subject><subject>Obesity - complications</subject><subject>Overweight</subject><subject>Pathogenesis</subject><subject>Patients</subject><subject>Serum levels</subject><subject>Transforming growth factor</subject><subject>Transforming Growth Factor beta - blood</subject><subject>Transforming growth factor-b</subject><issn>0730-2312</issn><issn>1097-4644</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp1kc9uEzEQxi1UREPhwAtUlnoBKWnH9u46PkJESlBULuG8cryzxNH-SW1vo9x4BHgVeA8egifBmy09VOppvvH89M1YHyFvGFwyAH61NetLLiXAMzJioOQkyZLkhIxACphwwfgpeen9FgCUEvwFORXAMwAxHZGfqw1SH7riQNuShr5B19W0wjus-qfF8u_3H8mYrq7nUfz5NaaL-U2vfo-pbophnlHb0PYO3R7tt02gOx0sNsHTvQ2bI9aLtgu0sHqNAT2tsaps6Pxxujns0AVsvG2bV-R5qSuPr-_rGfk6_7iafZosv1wvZu-XEyPS-C3EogS5NsAVYgYpV1olYioznUnQRk0zg6kqNKLhplTptFSMg5FpUpo0AyPOyNvBd-fa2w59yGvrTbxKN9h2PueMCS5TxlVELx6h27ZzTbwuUnFd9GNppN4NlHGt9w7LfOdsrd0hZ5D3OeUxp_yYU2TP7x27dY3FA_k_mAhcDcDeVnh42in_PPswWP4D3S6gWA</recordid><startdate>201903</startdate><enddate>201903</enddate><creator>Asadikaram, Gholamreza</creator><creator>Ram, Maryam</creator><creator>Izadi, Alireza</creator><creator>Sheikh Fathollahi, Mahmood</creator><creator>Nematollahi, Mohammad Hadi</creator><creator>Najafipour, Hamid</creator><creator>Shahoozehi, Bidollah</creator><creator>Mirhoseini, Mahboobeh</creator><creator>Masoumi, Mohammad</creator><creator>Shahrokhi, Nader</creator><creator>Arababadi, Mohammad Kazemi</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7T7</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>201903</creationdate><title>The study of the serum level of IL‐4, TGF‐β, IFN‐γ, and IL‐6 in overweight patients with and without diabetes mellitus and hypertension</title><author>Asadikaram, Gholamreza ; Ram, Maryam ; Izadi, Alireza ; Sheikh Fathollahi, Mahmood ; Nematollahi, Mohammad Hadi ; Najafipour, Hamid ; Shahoozehi, Bidollah ; Mirhoseini, Mahboobeh ; Masoumi, Mohammad ; Shahrokhi, Nader ; Arababadi, Mohammad Kazemi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3530-eedf07bc029ee60529a943876a670ac986ce59daeec2cf958f9120c754fc560c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Antihypertensive Agents - therapeutic use</topic><topic>Body weight</topic><topic>cytokine</topic><topic>Cytokines</topic><topic>Cytotoxicity</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Diabetes Mellitus, Type 2 - blood</topic><topic>Diabetes Mellitus, Type 2 - complications</topic><topic>Diabetes Mellitus, Type 2 - drug therapy</topic><topic>Diabetes Mellitus, Type 2 - pathology</topic><topic>Growth factors</topic><topic>Health risks</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Hypertension - blood</topic><topic>Hypertension - complications</topic><topic>Hypertension - drug therapy</topic><topic>Hypertension - pathology</topic><topic>Hypoglycemic Agents - therapeutic use</topic><topic>immune system</topic><topic>Inflammation</topic><topic>Interferon</topic><topic>Interferon-gamma - blood</topic><topic>Interleukin-4 - blood</topic><topic>Interleukin-6 - blood</topic><topic>Interleukins</topic><topic>Lymphocytes T</topic><topic>Male</topic><topic>Men</topic><topic>Middle Aged</topic><topic>obesity</topic><topic>Obesity - blood</topic><topic>Obesity - complications</topic><topic>Overweight</topic><topic>Pathogenesis</topic><topic>Patients</topic><topic>Serum levels</topic><topic>Transforming growth factor</topic><topic>Transforming Growth Factor beta - blood</topic><topic>Transforming growth factor-b</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Asadikaram, Gholamreza</creatorcontrib><creatorcontrib>Ram, Maryam</creatorcontrib><creatorcontrib>Izadi, Alireza</creatorcontrib><creatorcontrib>Sheikh Fathollahi, Mahmood</creatorcontrib><creatorcontrib>Nematollahi, Mohammad Hadi</creatorcontrib><creatorcontrib>Najafipour, Hamid</creatorcontrib><creatorcontrib>Shahoozehi, Bidollah</creatorcontrib><creatorcontrib>Mirhoseini, Mahboobeh</creatorcontrib><creatorcontrib>Masoumi, Mohammad</creatorcontrib><creatorcontrib>Shahrokhi, Nader</creatorcontrib><creatorcontrib>Arababadi, Mohammad Kazemi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cellular biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Asadikaram, Gholamreza</au><au>Ram, Maryam</au><au>Izadi, Alireza</au><au>Sheikh Fathollahi, Mahmood</au><au>Nematollahi, Mohammad Hadi</au><au>Najafipour, Hamid</au><au>Shahoozehi, Bidollah</au><au>Mirhoseini, Mahboobeh</au><au>Masoumi, Mohammad</au><au>Shahrokhi, Nader</au><au>Arababadi, Mohammad Kazemi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The study of the serum level of IL‐4, TGF‐β, IFN‐γ, and IL‐6 in overweight patients with and without diabetes mellitus and hypertension</atitle><jtitle>Journal of cellular biochemistry</jtitle><addtitle>J Cell Biochem</addtitle><date>2019-03</date><risdate>2019</risdate><volume>120</volume><issue>3</issue><spage>4147</spage><epage>4157</epage><pages>4147-4157</pages><issn>0730-2312</issn><eissn>1097-4644</eissn><abstract>Background
Obesity increases the risk of diabetes mellitus (DM) and hypertension. We aimed to analyze the serum levels of cytokines that have relevance to the pathologies including, interleukin‐4 (IL‐4), transforming growth factor‐β (TGF‐β), interferon‐γ (IFN‐γ), and IL‐6 cytokines of overweight men with DM and/or hypertension.
Methods
The study collected serum from 164 men. The sample population contained, 54 overweight men without DM or hypertension (control [CTL] group), 36 men with both DM and hypertension (DH group), 20 men with DM but no hypertension (D group), and 54 had hypertension without DM (H).
Results
The main results showed that the concentration of IFN‐γ in the DH group was significantly higher than the D, H, and CTL groups, IL‐6 in DH and D groups was significantly lower than the CTL group. The serum level of TGF‐β and IL‐4 cytokines did not show any significant differences across the four groups. Serum levels of IL‐6 were also significantly lower in untreated patients in D group than controls and in DH when compared with H groups.
Conclusion
In conclusion, it appears that the proinflammatory and anti‐inflammatory cytokines either play a significant role in the pathogenesis of hypertension and DM or serve as markers for these pathologies. Accordingly, increased serum levels of IFN‐γ may participate in the pathogenesis of hypertension in the diabetic patients and decreased IL‐6 is associated with type 2 DM.
•Obesity increases the risk of diabetes (D) and hypertension in cytokines dependent manners.
•Interferon‐γ in diabetes/hypertension (DH) patients is significantly higher than D, H, and controls (CTL). DH and D have lower interleukin‐6 than CTL. It is also lower in untreated cases in D group than CTL and in DH than H. Transforming growth factor β is higher in the treated than untreated patients in DH group.
•It seems that cytokines play a significant role in the pathogenesis of hypertension in diabetes.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>30260038</pmid><doi>10.1002/jcb.27700</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0730-2312 |
ispartof | Journal of cellular biochemistry, 2019-03, Vol.120 (3), p.4147-4157 |
issn | 0730-2312 1097-4644 |
language | eng |
recordid | cdi_proquest_miscellaneous_2113275129 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Antihypertensive Agents - therapeutic use Body weight cytokine Cytokines Cytotoxicity Diabetes Diabetes mellitus Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - pathology Growth factors Health risks Humans Hypertension Hypertension - blood Hypertension - complications Hypertension - drug therapy Hypertension - pathology Hypoglycemic Agents - therapeutic use immune system Inflammation Interferon Interferon-gamma - blood Interleukin-4 - blood Interleukin-6 - blood Interleukins Lymphocytes T Male Men Middle Aged obesity Obesity - blood Obesity - complications Overweight Pathogenesis Patients Serum levels Transforming growth factor Transforming Growth Factor beta - blood Transforming growth factor-b |
title | The study of the serum level of IL‐4, TGF‐β, IFN‐γ, and IL‐6 in overweight patients with and without diabetes mellitus and hypertension |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T05%3A06%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20study%20of%20the%20serum%20level%20of%20IL%E2%80%904,%20TGF%E2%80%90%CE%B2,%20IFN%E2%80%90%CE%B3,%20and%20IL%E2%80%906%20in%20overweight%20patients%20with%20and%20without%20diabetes%20mellitus%20and%20hypertension&rft.jtitle=Journal%20of%20cellular%20biochemistry&rft.au=Asadikaram,%20Gholamreza&rft.date=2019-03&rft.volume=120&rft.issue=3&rft.spage=4147&rft.epage=4157&rft.pages=4147-4157&rft.issn=0730-2312&rft.eissn=1097-4644&rft_id=info:doi/10.1002/jcb.27700&rft_dat=%3Cproquest_cross%3E2113275129%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3530-eedf07bc029ee60529a943876a670ac986ce59daeec2cf958f9120c754fc560c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2167056015&rft_id=info:pmid/30260038&rfr_iscdi=true |